Kamada Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Kamada Stock Summary

Kamada competes with Lifecore Biomedical, Shuttle Pharmaceuticals, Cumberland Pharmaceuticals, Ironwood Pharmaceuticals, and Organogenesis Holdings. It operates in two segments, Proprietary Products and Distribution. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. Kamada operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 355 people.

Kamada Key Financial Ratios

Kamada Key Balance Sheet Accounts

Kamada Key Income Statement Accounts

Kamada Key Cash Accounts

Kamada Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kamada's current stock value. Our valuation model uses many indicators to compare Kamada value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kamada competition to find correlations between indicators driving Kamada's intrinsic value. More Info.Kamada is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.45  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Kamada is roughly  2.23 . At present, Kamada's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kamada's earnings, one of the primary drivers of an investment's value.

Kamada's Earnings Breakdown by Geography

Kamada Systematic Risk

Today, most investors in Kamada Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Kamada's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Kamada growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Kamada help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kamada. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kamada based on widely used predictive technical indicators. In general, we focus on analyzing Kamada Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kamada's daily price indicators and compare them against related drivers.

When running Kamada's price analysis, check to measure Kamada's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kamada is operating at the current time. Most of Kamada's value examination focuses on studying past and present price action to predict the probability of Kamada's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kamada's price. Additionally, you may evaluate how the addition of Kamada to your portfolios can decrease your overall portfolio volatility.